Webinar
AI Is Coming to Medicine

Join Alumni Ventures CEO Mike Collins for an exclusive discussion on how artificial intelligence is transforming the future of medicine.
From accelerating drug discovery to enhancing diagnostics and personalizing patient care, AI is reshaping the healthcare industry at an unprecedented pace. In this webinar, we’ll explore the key innovations, investment opportunities, and challenges shaping this rapidly evolving space.
Whether you’re an investor, healthcare professional, or simply curious about the intersection of AI and medicine, this session will provide valuable insights into what’s ahead. Don’t miss this opportunity to hear from industry experts and gain a deeper understanding of the AI-driven revolution in healthcare.
Why Attend?
- HomeCutting-Edge Insights: Learn how AI is driving breakthroughs in medical research, treatment, and patient outcomes.
- HomeInvestment Potential: Explore how venture capital is fueling the next wave of AI-powered healthcare startups.
- HomeIndustry Impact: Understand the key challenges and ethical considerations of AI adoption in medicine.
Reserve your spot today for this forward-looking discussion. Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Mike has been involved in almost every facet of venturing, from angel investing to venture capital, new business and product launches, and innovation consulting. He is the CEO of Alumni Ventures and launched AV’s first alumni fund, Green D Ventures, where he oversaw the portfolio as Managing Partner and is now Managing Partner Emeritus. Mike is a serial entrepreneur who has started multiple companies, including Kid Galaxy, Big Idea Group (partially owned by WPP), and RDM. He began his career at VC firm TA Associates. He holds an undergraduate degree in Engineering Science from Dartmouth and an MBA from Harvard Business School.